RxDoctor Payments Data

Cecilia Wang

Psychiatry · Wayne, NJNPI 1083780753

Payments from drug & device makers

$5,769in general payments, 2019–2025

Across 459 payments — averaging $12.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$899
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$737
  • Teva Pharmaceuticals USA, Inc.$609
  • Takeda Pharmaceuticals U.S.A., Inc.$308
  • Johnson & Johnson$218
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$5,66098%
  • Education$1092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,769 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$153,467
Medicare patients
136
Services billed
1,885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$104,590
VraylarCariprazine Hcl26$38,544
TrintellixVortioxetine Hydrobromide24$12,263
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl90$8,315
Bupropion XlBupropion Hcl203$2,640
Paliperidone ErPaliperidone13$2,452
Divalproex Sodium41$1,823
Sertraline Hcl399$1,553
Aripiprazole41$1,413
Vilazodone Hcl19$1,298
Trazodone Hcl258$1,295
Duloxetine Hcl77$931
Escitalopram Oxalate99$888
Quetiapine Fumarate54$857
Hydroxyzine Pamoate98$742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$30$104,59013 claims
AbbVieVraylar$1,349$38,54426 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$308$12,26324 claims
Almatica Pharma LLCSertraline Hcl$14$1,553399 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →